Association between Insertion-Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Treatment Response to Antipsychotic Medications: A Study of Antipsychotic-Naïve First-Episode Psychosis Patients and Nonadherent Chronic Psychosis Patients

Autor: Sergej Nadalin, Sanja Dević Pavlić, Vjekoslav Peitl, Dalibor Karlović, Lena Zatković, Smiljana Ristić, Alena Buretić-Tomljanović, Hrvoje Jakovac
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Male
Angiotensins
Genotype
BIOMEDICINE AND HEALTHCARE. Basic Medical Sciences. Immunology
Peptidyl-Dipeptidase A
Catalysis
angiotensin‐converting enzyme (ACE)
polymorphism
Inorganic Chemistry
BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Psihijatrija
BIOMEDICINE AND HEALTHCARE. Basic Medical Sciences. Human Genetics
Genomics and Proteomics

Humans
Physical and Theoretical Chemistry
Molecular Biology
Spectroscopy
Metabolic Syndrome
psychiatry_mental_health_studies
Organic Chemistry
treatment response
General Medicine
BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Psychiatry
Lipids
antipsychotic medication
Computer Science Applications
angiotensin-converting enzyme (ACE)
insertion/deletion
Glucose
Psychotic Disorders
BIOMEDICINA I ZDRAVSTVO. Temeljne medicinske znanosti. Imunologija
Female
BIOMEDICINA I ZDRAVSTVO. Temeljne medicinske znanosti. Genetika
genomika i proteomika čovjeka

Antipsychotic Agents
Zdroj: International Journal of Molecular Sciences
Volume 23
Issue 20
International Journal of Molecular Sciences; Volume 23; Issue 20; Pages: 12180
ISSN: 1422-0067
Popis: We investigated whether a functional insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme (ACE) influenced antipsychotic treatment. At baseline, and after 8 weeks of treatment with various antipsychotic medications, we assessed patients’ Positive and Negative Syndrome Scale (PANSS) scores, PANSS factors, and metabolic syndrome-related parameters (fasting plasma lipid and glucose levels, and body mass index). A total of 186 antipsychotic-naïve first-episode psychosis patients or nonadherent chronic psychosis individuals (99 males and 87 females) were genotyped by polymerase chain reaction analysis. The ACE-I/D polymorphism was significantly associated with changes in PANSS psychopathology only (p < 0.05). Compared to ACE-II homozygous males, ACE-DD homozygous and ACE-ID heterozygous males manifested significantly greater decreases in PANSS positive score, PANSS excitement factor, and PANSS cognitive factor. ACE-DD homozygous females manifested higher decreases in PANSS depression factor compared to ACE-II homozygous and ACE-ID heterozygous females. The polymorphism’s effect size was estimated as moderate to strong, while its contribution to the PANSS psychopathology ranged from ~5.4–8.7%, with the lowest contribution observed for PANSS positive score changes and the highest for PANSS depressive factor changes. Our results indicated that ACE-I/D polymorphism had a statistically significant but weak gender-specific impact on psychopathology data and showed no association between ACE-I/D polymorphism and metabolic syndrome-related parameters.
Databáze: OpenAIRE